Home » Posts tagged 'seeing machines'
Tag Archives: seeing machines
Ian Pollard – Seeing Machines #SEE hit by production delays
Seeing Machines Ltd SEE has been hit by its manufacturing partner delaying delivery of a number of units by some six weeks. Sales of these units have been agreed but the delay means the resulting sales revenue will not now be received within the current financial year. Sales revenue is now expected to be between A$30 to A$35m instead of the anticipated A$38 to A$43m.but this still represents a doubling of last years sales.
SigmaRoc plc SRC reports a strong year in 2017 as it exceeded expectations. The losses of 2016 were all turned into gains with 2017 EBITDA rising by 37% on sales up by 11% and on an underlying basis 2016’s loss of £2.4m. was turned into a profit before tax of £2.6m. whilst earnings er share came in at 2p. compared to a loss of 1.4p. The company says that it has now established a solid platform for growth.
UVENCO UK plc UVEN announced a week ago that it was in discussion with a third party about a possible sale. However it has now announced that the third party is no longer interested in buying any of its trading subsidiaries as a going concern. Instead it has made an offer to acquire the assets only or alternatively acquire Drinkmaster only, as a going concern.The Board is meeting its advisors today.
Gateley Holdings plc GTLY updates that second half trading has remained strong with the Property and Corporate Businesses each recording not less than 15% fee growth. Revenue for the year to 31st April is expected to be 84m.as against 77.6m in 2017 and It is anticipated that the final dividend will be in accordance with stated policy of distributing up to 70% of after tax profits.
Beachfront Property for sale in Greece; http://www.hiddengreece.net
ABF Expects Good Full Year Growth From Primark
AB Foods ABF Markdowns at Primark have fallen even more since the third quarter, further improving the outlook for the full year to the 16th September. Good growth is now expected in both adjusted operating profit and earnings per share. The weakness of sterling has also played its part and will provide a currency windfall of some £85m.
Restore plc RST has produced strong organic growth across the group for the half year to the 30th June and the interim dividend is to be increased by 26% to 1.67p pr share. Like for like revenue rose by 57%, EBITDA and profit before tax were both up by 59% and earnings per share by 38%. It is anticipated that the full year performance will be slightly ahead of previous expectations.
Pennant Group PEN managed to deliver a pre tax profit for the six months to the 30th June with revenue rising from £6.6m. to £9m. Profit before tax rose from a lowly £10,582 in the first half of 2016 to £935,353 and earnings per share showed a similar sharp rise from 0.04 to 2.84p per share. Delays in a major UK contract however, mean that for the full year revenues will be below current market expectations. in the longer term, the company has a strong order book and an encouraging pipeline for the three years to 2020 and beyond.
Seeing Machines Ltd. SEE saw second half sales rise by 250% over the first half and full year Fleet business at A$9.1m almost tripled that of 2016. The Fleet business is described as being a tremendous success with strong growth in the markets in which it participates. The strong momentum is expected to continue in 2018. However continuing major investment has meant that the net loss before tax has soared from last years A$1.6m to A$28.5m.
Science in Sport plc SIS has reached agreement with Team Sky for the renewal of its contract for a further three years.
Villas & houses for sale in Greece – visit; http://www.hiddengreece.net
Daily Actions – UK Main & AIM markets 08032016
Daily Actions is a daily summary analysis of changes in short term actions from our Daily Recs – AIM and Daily Recs Main markets reports. This report is typically distributed before the open of trading in London
AIM Market
ST Rec. changed | ||
From | To | |
Basic Resources | ||
Altona Energy | Buy | Neutral |
Ariana Resources | Buy | Neutral |
Avocet Mining | Sell | Buy |
Goldstone Resources | Neutral | Buy |
Minco | Buy | Neutral |
Zincox Resources | Buy | Neutral |
Construction | ||
Michelmersh Brick Holdings | Buy | Neutral |
Financial Services | ||
Amphion Innovations | Buy | Neutral |
Tengri Resources | Buy | Neutral |
Fletcher King | Buy | Neutral |
Impax Asset Management Group | Buy | Neutral |
Park Group | Buy | Neutral |
Food & Beverage | ||
Asian Citrus Holding (London) | Sell | Neutral |
Distil | Buy | Neutral |
M P Evans Group | Buy | Neutral |
Health Care | ||
Omega Diagnostics Group | Buy | Neutral |
ReNeuron Group | Buy | Neutral |
Verona Pharma | Buy | Neutral |
Industrial Good & Services | ||
Angle | Buy | Neutral |
Cap-XX | Neutral | Buy |
Dart Group | Neutral | Sell |
Nakama Group | Buy | Neutral |
The Kellan Group | Buy | Neutral |
Maintel Holdings | Buy | Neutral |
Media | ||
Mirada | Buy | Neutral |
Oil & Gas – Explorers | ||
Ascent Resources | Neutral | Buy |
Bowleven | Buy | Neutral |
Solo Oil | Buy | Neutral |
Oil & Gas – Producers | ||
Hydrodec Group | Neutral | Buy |
Northern Petroleum | Neutral | Buy |
Pantheon Resources | Buy | Neutral |
Retail | ||
Stanley Gibbons Group | Buy | Neutral |
Technology | ||
Seeing Machines | Neutral | Buy |
Simigon | Buy | Neutral |
SQS Software Quality Systems | Buy | Neutral |
Telecommunications | ||
MXC Capital | Buy | Neutral |
Travel & Leisure | ||
Tasty | Buy | Neutral |
Utilities | ||
KSK Power Ventur | Buy | Neutral |
Main Market
ST Rec. changed | ||
From | To | |
Aerospace & Defence | ||
Cobham | Buy | Neutral |
Heavy Construction | ||
Carillion | Sell | Neutral |
House Construction | ||
Redrow | Buy | Neutral |
Insurance | ||
Admiral Group | Neutral | Sell |
Media & Entertainment | ||
ITV | Buy | Neutral |
Photo-Me International | Sell | Neutral |
Oil & Gas | ||
Hunting | Sell | Neutral |
Support Services | ||
Diploma | Sell | Neutral |
RISK WARNING
Intellisys Intelligent Analysis Limited (‘Intellisys’) does not make personal recommendations. The information in this publication is provided solely to enable you to make your own investment decisions. If you are unsure about dealing in shares and other equity investments, you must contact your financial adviser as these types of investments may not be suitable for everyone. The value of stocks and shares, and the income from them, can fall as well as rise and you may not get back the full amount you originally invested. If denominated in a foreign currency, fluctuations in the exchange rate will also affect the value of stocks and shares and the income from them. Past performance is not necessarily a guide to future performance. You agree to abide fully with Intellisys’ Term & Conditions, which are available to www.intellisys.uk.com
The full reports are available from Intellisys Intelligent Analysis website (www.intellisys.uk.com) by clicking on the ‘Research’ tab.
DISCLAIMER: Intellisys Intelligent Analysis Limited has prepared this report. Intellisys (“Intellisys”) is the trading name of Intellisys Intelligent Analysis Limited. Intellisys Intelligent Analysis Limited is a provider of financial research reports that indicate the possible value of quoted company shares. The information contained within any and all of Intellisys’ reports are designed to present an objective assessment of the possible value or relative value of a company and/or an actuarial sector or stock market index. Intellisys utilises as extensive as possible range of valuation tools and proprietary systems to derive its outputs. The base data for the models are derived from sources believed to be accurate but Intellisys Intelligent Analysis Limited does not warrant or guarantee the accuracy or reliability of the source data or its models and proprietary systems. Subscribers, and casual readers, should not rely upon the Intellisys’ research outputs when forming specific investment decisions but should seek advice specific to their situation and investment requirements from a person authorised under the Financial Services and Markets Act 2000, before entering into any investment agreement.Intellisys Intelligent Analysis Limited has used reasonable care and skill in compiling the content of this report. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness or accuracy of the information and no responsibility or liability is accepted to the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. In no event will Intellisys Intelligent Analysis Limited, Intellisys or any of its officers, employees or agents be liable to any other party for any direct, indirect, special or other consequential damages arising from the use of this report.
The Intellisys Intelligent Analysis Limited and/or Intellisys reports are not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the publication or availability of the Intellisys Intelligent Analysis Limited and/or Intellisys information may be prohibited. Persons in respect of whom such prohibitions apply must not access the Intellisys Intelligent Analysis Limited and/or Intellisys reports. Neither this document, nor any copy in whatever form of media, may be taken or transmitted into the United States, Canada, Australia, Ireland, South Africa or Japan or into any jurisdiction where it would be unlawful to do so. Any failure to comply with this restriction may constitute a violation of relevant local securities laws. Recipients of Intellisys Intelligent Analysis Limited and/or Intellisys reports outside the UK are not covered by the rules and regulations made for the protection of investors in the UK. Any user distributing information taken from any Intellisys Intelligent Analysis Limited or Intellisys report and/or the Intellisys website, in whatever form, to any other person, agrees to attach a copy of this Disclaimer and the Terms and Conditions of Use pages and obtain the agreement of such other person to comply with the terms set forth. Intellisys’ published reports are published for information purposes and only available to market counterparties, high net-worth and sophisticated individual investors. No Intellisys report constitutes an offer or invitation to trade, sell, purchase or acquire any shares or other financial instruments in any company or any interest therein, nor shall it form the basis of any contract entered into for the sale of shares or any other financial instrument in any company. Intellisys Intelligent Analysis Limited believes that the information within each and any of its reports to be correct, but its accuracy or completeness cannot be guaranteed. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or mis-statements, negligent or otherwise. Intellisys Intelligent Analysis Limited (including its Directors, employees and representatives) or a connected person may have positions in or options or other financial instruments on any of the securities mentioned within a report, and may buy, sell or offer to purchase or sell such securities from time to time, subject to restrictions imposed by internal rules. Subscribers, and casual reader, are reminded that the value of any financial instrument may go up or down and that past performance is not necessarily a guide to future performance. Intellisys Intelligent Analysis Limited is not registered with or regulated by any financial regulatory authority and does not offer, provide or purport to provide or offer investment advice. Intellisys Intelligent Analysis Limited can be contacted at Woodfield Cottage, The Street, Mortimer, Berkshire, United Kingdom RG7 3DW. |